Various research has examined the OGF-OGFr axis across different cancer types, with some studies supporting the dysregulation of the pathway, especially in more aggressive and less differentiated tumors, and others reporting that the axis is maintained as intact or is only minimally altered [27,56,57]. This evidence concerns the gene OGFR and cancer.